Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Follow Bar and Bench channel on WhatsApp

Download the Bar and Bench Mobile app for instant access to the latest legal news.

Also Read

There should be acknowledgement of Ustad Dagar: Supreme Court to AR Rahman in Veera Raja Veera copyright case

VERTICES PARTNERS, Bharucha act on Marico's ₹225 crore majority stake acquisition in Cosmix

Not every terminable contract is determinable to resist specific performance: Supreme Court clarifies

Varun Prabhakar rejoins Devyani International as General Counsel

CJI office received 8,630 complaints against sitting judges in last 10 years: Law Ministry in Lok Sabha

SCROLL FOR NEXT